These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 12207149)

  • 1. Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden.
    Kalb B; Matell G; Pirskanen R; Lambe M
    Neuroepidemiology; 2002; 21(5):221-5. PubMed ID: 12207149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data.
    Keovilayhong S; Mulliez A; Feral L; Chenaf C; Clavelou P; Moisset X; Taithe F; Poncet Megemont L
    Rev Neurol (Paris); 2024 May; 180(5):451-458. PubMed ID: 38582663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of myasthenia gravis.
    Phillips LH
    Ann N Y Acad Sci; 2003 Sep; 998():407-12. PubMed ID: 14592908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of myasthenia gravis].
    Pekmezović T; Lavrnić D; Jarebinski M; Apostolski S
    Srp Arh Celok Lek; 2006; 134(9-10):453-6. PubMed ID: 17252917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime course of myasthenia gravis.
    Grob D; Brunner N; Namba T; Pagala M
    Muscle Nerve; 2008 Feb; 37(2):141-9. PubMed ID: 18059039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balancing WNT signalling in early forebrain development: The role of LRP4 as a modulator of LRP6 function.
    Geng S; Paul F; Kowalczyk I; Raimundo S; Sporbert A; Mamo TM; Hammes A
    Front Cell Dev Biol; 2023; 11():1173688. PubMed ID: 37091972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of TSHR gene single nucleotide intronic polymorphism with the risk of hypothyroid and hyperthyroid disorders in Yazd province.
    Naghibi FS; Miresmaeili SM; Javid A
    Sci Rep; 2022 Sep; 12(1):15745. PubMed ID: 36130976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.
    Salari N; Fatahi B; Bartina Y; Kazeminia M; Fatahian R; Mohammadi P; Shohaimi S; Mohammadi M
    J Transl Med; 2021 Dec; 19(1):516. PubMed ID: 34930325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Myasthenia Gravis in Sweden 2006-2016.
    Westerberg E; Punga AR
    Brain Behav; 2020 Nov; 10(11):e01819. PubMed ID: 32869520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression in myasthenia gravis: a heterogeneous and intriguing entity.
    Gavrilov YV; Alekseeva TM; Kreis OA; Valko PO; Weber KP; Valko Y
    J Neurol; 2020 Jun; 267(6):1802-1811. PubMed ID: 32140868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic Crisis Caused by Cholinesterase Inhibitors: a Retrospective Nationwide Database Study.
    Ohbe H; Jo T; Matsui H; Fushimi K; Yasunaga H
    J Med Toxicol; 2018 Sep; 14(3):237-241. PubMed ID: 29907949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celiac disease and risk of myasthenia gravis - nationwide population-based study.
    Thawani SP; Brannagan TH; Lebwohl B; Green PHR; Ludvigsson JF
    BMC Neurol; 2018 Mar; 18(1):28. PubMed ID: 29529996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylcholine Receptor Antibody Titers and Clinical Course after Influenza Vaccination in Patients with Myasthenia Gravis: A Double-Blind Randomized Controlled Trial (ProPATIent-Trial).
    Tackenberg B; Schneider M; Blaes F; Eienbröker C; Schade-Brittinger C; Wellek A; Deschauer M; Eickmann M; Klenk HD; Müller HH; Sommer N
    EBioMedicine; 2018 Feb; 28():143-150. PubMed ID: 29337134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Sensitive Method for Detecting Peptide-specific CD4
    Sharma S; Malmeström C; Lindberg C; Meisel S; Schön K; Verolin M; Lycke NY
    Front Immunol; 2017; 8():1370. PubMed ID: 29114250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries.
    Sabre L; Westerberg E; Liik M; Punga AR
    Brain Behav; 2017 Apr; 7(4):e00653. PubMed ID: 28413704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early onset bilateral juvenile myasthenia gravis masquerading as simple congenital ptosis.
    Alam MS; Devi Nivean P
    GMS Ophthalmol Cases; 2017; 7():Doc07. PubMed ID: 28293536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of quality of life in Brazilian patients with myasthenia gravis.
    Mourão AM; Gomez RS; Barbosa LS; Freitas Dda S; Comini-Frota ER; Kummer A; Lemos SM; Teixeira AL
    Clinics (Sao Paulo); 2016 Jul; 71(7):370-4. PubMed ID: 27464292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of 424 childhood-onset myasthenia gravis patients.
    Gui M; Luo X; Lin J; Li Y; Zhang M; Zhang X; Yang M; Wang W; Bu B
    J Neurol; 2015; 262(4):823-30. PubMed ID: 25588729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of MuSK in synapse formation and neuromuscular disease.
    Burden SJ; Yumoto N; Zhang W
    Cold Spring Harb Perspect Biol; 2013 May; 5(5):a009167. PubMed ID: 23637281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity.
    Sardu C; Cocco E; Mereu A; Massa R; Cuccu A; Marrosu MG; Contu P
    PLoS One; 2012; 7(3):e32487. PubMed ID: 22396771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.